Menna Grazia, Battistelli Marco, Rapisarda Alessandro, Izzo Alessandro, D'Ercole Manuela, Olivi Alessandro, Montano Nicola
Department of Neuroscience, Neurosurgery Section, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
Department of Neurosurgery, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
Brain Sci. 2022 Apr 29;12(5):583. doi: 10.3390/brainsci12050583.
There is a lack of knowledge about the factors associated with the recurrence of hemifacial spam (HFS) following an initially successful microvascular decompression (MVD) surgery. The aim of the present study was to systematically review the pertinent literature and carry out a meta-analysis of factors linked to HFS recurrence in patients undergoing initially successful MVD treatment. An online literature search was launched on the PubMed/Medline and Scopus databases. The following data were collected: sex, age at surgery, affected side, reported improvement after surgery, presence of post-operatory facial weakness, symptom duration, offender vessels, and data obtained from intraoperative neurophysiological monitoring. Upon full-text review, eight articles were included, studying 1105 patients, of which 64 (5.7%) reported recurrence after MVD surgery for hemifacial spasm. There was a statistically significant increased incidence of HFS recurrence in patients with the persistence of lateral spread response (LSR after surgery (OR 9.44 (95% CI 1.69-52.58) 0.01), while those patients experiencing a shorter disease duration before going to surgery were significantly less prone to experiencing disease recurrence (OR 0.11 (95% CI 0.03-0.46) 0.002). The remaining examined factors did not result as significantly associated with the risk of recurrence. The funnel plots were largely symmetrical for each variable studied. Taken together, the results of our meta-analysis seem to suggest that short-term symptom duration is a protective factor against HFS recurrence after MVD surgery, while LSR persistence is a negative prognostic factor. Well-designed randomized controlled clinical trials with a long follow-up are expected to further explore therapeutic alternatives for HFS recurrence.
对于初次微血管减压术(MVD)成功后出现的半面痉挛(HFS)复发相关因素,人们了解不足。本研究的目的是系统回顾相关文献,并对初次MVD治疗成功的患者中与HFS复发相关的因素进行荟萃分析。我们在PubMed/Medline和Scopus数据库上进行了在线文献检索。收集了以下数据:性别、手术年龄、患侧、术后报告的改善情况、术后面部无力的存在情况、症状持续时间、责任血管,以及术中神经生理监测获得的数据。经全文审查,纳入了8篇文章,共研究了1105例患者,其中64例(5.7%)报告在MVD治疗半面痉挛后复发。术后存在侧方扩散反应(LSR)持续的患者中,HFS复发的发生率有统计学意义的增加(OR 9.44(95% CI 1.69 - 52.58),P = 0.01),而术前病程较短的患者疾病复发的可能性显著降低(OR 0.11(95% CI 0.03 - 0.46),P = 0.002)。其余检查的因素与复发风险无显著相关性。所研究的每个变量的漏斗图基本对称。综合来看,我们的荟萃分析结果似乎表明,短期症状持续时间是MVD术后预防HFS复发的保护因素,而LSR持续存在是不良预后因素。预计设计良好且随访时间长的随机对照临床试验将进一步探索HFS复发的治疗替代方案。